Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580047 · ClinicalTrials.gov registry record · NA
Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT00580047 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 59 participants.
The verdict
NCT00580047, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The study is designed to look at the effect of different bone treatment plans on bone loss after kidney or kidney/pancreas transplant.
Interventions
- DRUG Zoledronic Acid
- DRUG Alendronate
- COMBINATION_PRODUCT Calcium with vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2003-12-01 |
| Est. Completion | 2014-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580047
The ClinicalTrials.gov registry entry for NCT00580047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Zoledronic Acid is the first listed.
NCT00580047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00580047 about?
NCT00580047 is a clinical study titled "Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants". The study is designed to look at the effect of different bone treatment plans on bone loss after kidney or kidney/pancreas transplant.
What is the current status of trial NCT00580047?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2003-12-01. Estimated completion is 2014-07-29.
What interventions are being tested in trial NCT00580047?
The interventions under investigation include: Zoledronic Acid (DRUG), Alendronate (DRUG), Calcium with vitamin D (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00580047?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.